Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 39 minutes ago
Back to Filings
FORM 4
AI

Insider Trading - September 18, 2025

Filed September 18, 2025
·
Period ending September 16, 2025
·
0002001011-25-000076

SVP Kampani sold 40,601 shares (~$2M) via 10b5-1 & RSU sell-to-cover.

Brief

Arjun Kampani, SVP General Counsel, sold 40,601 shares of RKLB on Sep 16-17, 2025, through multiple transactions. Sales consisted of sell-to-cover for RSU vesting taxes and automatic 10b5-1 plan executions. Neutral signal due to pre-planned, non-discretionary nature.

Detailed Brief

Arjun Kampani, SVP General Counsel of Rocket Lab USA Inc., reported sales of 40,601 common shares across transactions on 09/16/2025 (31,185 shares at weighted prices $47.79-$51.63) and 09/17/2025 (9,416 shares at $47.18-$47.95). The 09/16 sales were sell-to-cover to satisfy tax withholding on RSU vesting, while 09/17 sales were automatic under a Rule 10b5-1 plan adopted on Dec 12, 2024. Post-transaction direct holdings: 489,629 shares. Form indicates 10b5-1 compliance. No derivative transactions. This appears routine for executive compensation events, with no indication of discretionary selling or unusual patterns.

Key Telemetry

  • Sold 40,601 shares (8% of post-transaction 489,629 direct holdings).
  • Sell-to-cover for RSU taxes on 9/16; 10b5-1 automatic sales on 9/17 (plan from Dec 2024).
  • Executed at $47-$52/share amid elevated prices.
  • Routine compensation-related; first such filing noted, no cluster selling.

Impact Vector

Neutral signal on insider confidence; transactions were pre-scheduled under 10b5-1 plan and mandatory tax withholdings, not indicative of pessimism or discretionary liquidation.

Search
Search across missions, customers, news, and SEC filings